5501 results about "Hydrogen bond" patented technology

Disclosed is a phase change ink composition comprising a colorant and an ink vehicle, the ink being a solid at temperatures less than about 50° C. and exhibiting a viscosity of no more than about 20 centipoise at a jetting temperature of no more than about 160° C., wherein at a first temperature hydrogen bonds of sufficient strength exist between the ink vehicle molecules so that the ink vehicle forms hydrogen-bonded dimers, oligomers, or polymers, and wherein at a second temperature which is higher than the first temperature the hydrogen bonds between the ink vehicle molecules are sufficiently broken that fewer hydrogen-bonded dimers, oligomers, or polymers are present in the ink at the second temperature than are present in the ink at the first temperature, so that the viscosity of the ink at the second temperature is lower than the viscosity of the ink at the first temperature.

A birefringent film which comprises a compound having a proton-accepting group and a compound having a proton-donating group; and a birefringent film which comprises a compound having a proton-accepting group and a proton-donating group. The proton-accepting group and proton-donating group are combined with each other through intermolecular hydrogen bonding.

Melanocortin receptor-specific compounds of the general formulas

and pharmaceutically acceptable salts thereof, where J is a substituted or unsubstituted monocyclic or bicyclic ring structure, L is a linker, W is a heteroatom unit with at least one cationic center, hydrogen bond donor or hydrogen bond acceptor, Q includes a substituted or unsubstituted aromatic carbocyclic ring, R₆, R₇, y and z are as defined in the specification, and the carbon atom marked with an asterisk can have any stereochemical configuration, and optionally with one or two additional ring substituents as defined, which compounds bind to one or more melanocortin receptors and are optionally an agonist, a partial agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist, and may be employed for treatment of one or more melanocortin receptor-associated conditions or disorders, and methods for the use of the compounds of the invention.

A medical device comprising radiopaque water-dispersible metallic nanoparticles, wherein the nanoparticles are released from the medical device upon implantation of the device. The medical device of the present invention is sufficiently radiopaque for x-ray visualization during implantation, but loses its radiopacity after implantation to allow for subsequent visualization using more sensitive imaging modalities such as CT or MRI.

The nanoparticles are formed of a metallic material and have surface modifications that impart water-dispersibility to the nanoparticles. The nanoparticles may be any of the various types of radiopaque water-dispersible metallic nanoparticles that are known in the art. The nanoparticles may be adapted to facilitate clearance through renal filtration or biliary excretion. The nanoparticles may be adapted to reduce tissue accumulation and have reduced toxicity in the human body. The nanoparticles may be applied directly onto the medical device, e.g., as a coating, or be carried on the surface of or within a carrier coating on the medical device, or be dispersed within the pores of a porous layer or porous surface on the medical device. The medical device itself may be biodegradable and may have the nanoparticles embedded within the medical device itself or applied as or within a coating on the biodegradable medical device. The nanoparticles may be released by diffusion through the carrier coating, disruption of hydrogen bonds between the nanoparticles and the carrier coating, degradation of the nanoparticle coating, degradation of the carrier coating, diffusion of the nanoparticles from the medical device, or degradation of the medical device carrying the nanoparticles.

Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.

The present invention provides a device having at least one constriction that is sized to permit translocation of only a single copy of the molecule. The device has a pair of spaced apart sensing electrodes that border the constriction, which may be a nanopore. The first electrode is connected to a first affinity element and the second electrode is connected to a second affinity element. The first and second affinity elements are configured to temporarily form hydrogen bonds with first and second portions of the target molecule as the latter passes through the constriction.

A silicon-based anode comprises an alginate-containing binder. The many carboxy groups of alginate bind to a surface of silicon, creating strong, rigid hydrogen bonds that withstand battery cycling. The alginate-containing binder provides good performance to the anode by (1) improving the capacity of the anode in comparison to other commercially-available binders, (2) improving Columbonic efficiency during charging and discharging cycles, and (3) improving stability during charging and discharging cycles.

The invention relates to a graphene-organic material layered assembly film and a preparation method thereof. The preparation method comprises: using a graphene material and an organic material as raw materials, utilizing interaction of static electricity, hydrogen bonds, coordinate bonds or charge transfer and the like between the graphene and the organic material, and superposing films layer by layer through the film preparation methods such as spin coating, spraying, dipping, lifting and pulling and the like to prepare the film, wherein the thickness of each layer of the film can be controlled between 10 nanometers and 2 millimeters according to requirement. The layered assembly film and the preparation method have the characteristics that multilayer film materials with different functions are prepared by utilizing unique electric, magnetic, mechanical and chemical properties of the grapheme, and can be used as biomaterials, conductive materials, electromagnetic shielding and wave absorbing materials, photovoltaic materials, electrode materials, film filtering and separating materials, and the like to be applied to chemistry and chemical industry, biology and precision instruments, and manufacture of micro electrons, machinery and aviation and aerospace devices according to the selected different organic materials.

A fiberglass non-woven binder composition containing a carboxy-functional copolymer binder crosslinker and a compound capable of forming a hydrogen-bonding complex with the carboxy-functional copolymer binder. The binder composition provides a strong, yet flexible bond that allows a compressed fiberglass mat to easily expand once the compression is released. The binder composition is capable of being cured at lower cure temperatures than those binders prepared using conventional crosslinkers.

A method of forming a thin film with a low hydrogen contents is provided by positioning a substrate inside a processing chamber, and supplying reacting materials into the chamber, chemisorbing a portion of the reacting materials onto the substrate. Then, a nitrogen (N2) remote plasma treatment is performed to reduce the hydrogen content of thin film layer formed by chemisorption of the reacting materials on the substrate. Accordingly, a thin film is formed having a low hydrogen content, since the hydrogen bonds in the thin film layer formed by chemisorption of the reacting materials are removed.

The present invention provides a treatment for enhancing the ability of the body to heal wounds. A topical cream is described which improves blood flow by the transdermal delivery of the nitric oxide precursor L-Arginine either alone or with an adjunct, theophylline. The delivery of the active agents is accomplished by use of a vehicle which contains a hostile biophysical environment which is also hostile to hydrogen bond formation.

To provide novel semiconductor light-emitting device member superior in transparency, light resistance, and heat resistance and capable of sealing semiconductor light-emitting device and holding phosphor without generating cracks or peelings even after use for a long time, the member meets the following requirements: (1) comprising functional group forming hydrogen bond with hydroxyl group or oxygen in a metalloxane bond, on the surface of ceramic or metal, (2) maintenance rate of transmittance at 400 nm wavelength before and after left at 200° C. for 500 hours is between 80% to 110%, (3) no change is observed by visual inspection after irradiated with light having 380 nm to 500 nm wavelength, whose center wavelength is between 400 nm and 450 nm both inclusive, for 24 hours with 4500 W/m² illumination intensity at 436 nm wavelength, and (4) refractive index at 550 nm wavelength is 1.45 or larger.

The present invention relates to an absorbent material that can be used as an absorbent core in absorbent articles such as sanitary napkins, pantiliners, incontinence products, disposable diapers, etc. The material of the present invention is a nonwoven sheet, consisting of cellulosic fibers, optionally superabsorbent polymeric material, containing no binders, latexes, etc, relying on hydrogen bonding to produce the necessary structure. The material contains density gradients which direct fluid into the material and distribute it providing more effective fluid transport and efficient utilization of storage capacity. The material consists of two regions. In the first region, the material has a low-density stratum adjacent to one surface, overlaying at least one higher density stratum adjacent to the opposite surface of the sheet. These strata create a density gradient in the thickness direction (Z-direction) of the sheet. The second region consists of a fluid distribution structure that has a higher density than at least the lower density of the strata comprising the first region. The fluid distribution structure is in direct fluid communication with the adjacent strata in the first region, along their boundaries.

The invention relates to a preparation method of a three-dimensional fiber-based aerogel material and a product thereof. The preparation method comprises the following steps of: firstly dispersing fibers in solvents which do not have fiber solubility to form turbid liquid; secondly curing the turbid liquid to form cured pieces; thirdly removing cured solvents in the cured pieces to form non-crosslinked fiber-based aerogel; and finally carrying out crosslinking stabilization treatment on the non-crosslinked fiber-based aerogel to obtain the fiber crossing point bonded and fixed three-dimensional fiber-based aerogel material. The product is a three-dimensional network-shaped material formed through mutual penetration and stagger of fibers. The fiber crossing points are effectively interconnected through non-hydrogen-bond bonding. The three-dimensional fiber-based aerogel material has volume density of 0.1-500mg/cm<3>, average pore size of 0.01-2000mu m and specific surface area of 0.2-2000m<2>/g. The preparation method and the product have the advantages that the preparation process is simple; the raw material limitations are less; and the aerogel product has good flexibility and connectivity and has broad application prospects in numerous fields.

The present invention relates to polymer compositions formed from a reactive mixture comprising at least one substantially non-reactive prepolymer comprising silicone containing groups and compatibilizing groups and a hydrophilic component comprising at least one monomer capable of hydrogen bonding with said prepolymer.

Methods are provided for purifying peptides and proteins by incorporating the peptide or protein into a diketopiperazine or competitive complexing agent to facilitate removal of one or more impurities from the peptide or protein. Formulations and methods also are provided for the improved transport of active agents across biological membranes, resulting for example in a rapid increase in blood agent concentration. The formulations include microparticles formed of (i) the active agent, which may be charged or neutral, and (ii) a transport enhancer that masks the charge of the agent and/or that forms hydrogen bonds with the target biological membrane in order to facilitate transport. In one embodiment insulin is administered via the pulmonary delivery of microparticles comprising fumaryl diketopiperazine and insulin in its biologically active form. This method of delivering insulin results in a rapid increase in blood insulin concentration that is comparable to the increase resulting from intravenous delivery.

The invention relates to a preparation method of a three-dimensional fiber-based aerogel tissue engineering scaffold and a product thereof. The preparation method comprises the following steps of: firstly dispersing fibers in solvents to form turbid liquid; secondly curing the turbid liquid to form cured pieces; thirdly removing cured solvents to form non-crosslinked fiber-based aerogel; finally carrying out crosslinking stabilization treatment and then carrying out sterilization treatment, thus obtaining the three-dimensional fiber-based aerogel tissue engineering scaffold. The product is a three-dimensional network-shaped material formed through mutual penetration and stagger of fibers. The fiber crossing points are effectively interconnected through non-hydrogen-bond bonding. The three-dimensional fiber-based aerogel tissue engineering scaffold has volume density of 0.1-500mg/cm<3>, average pore size of 0.01-2000mu m and specific surface area of 0.2-2000m<2>/g. The preparation method and the product have the advantages that the preparation process is simple; the raw material limitations are less; the aerogel tissue engineering scaffold product has good flexibility, connectivity and tissue growing environment and has broad application prospects in the tissue engineering field.

The invention discloses a high-strength supramolecular hydrogel and a preparation method and application thereof. The high-strength supramolecular hydrogel is prepared by using acryloyl glycinamide as a monomer and triggering in the presence of an initiator; because of the synergistic effect of hydrogen bonds, the supramolecular hydrogel is high in tensile strength and anti-tear while being compressed, can realize functions of thermoplasticity and self-repair at a high temperature, and is good in biocompatibility.

A method for depositing a low dielectric constant film having a dielectric constant of about 3.0 or less, preferably about 2.5 or less, is provided by using one or more cyclic organic precursors and one or more aliphatic precursors. In one aspect, a cyclic organosilicon compound, an aliphatic organosilicon, and an aliphatic hydrocarbon compound are reacted with an oxidizing gas at conditions sufficient to deposit a low dielectric constant film on the semiconductor substrate. The cyclic organosilicon compound includes at least one silicon-carbon bond. The aliphatic organosilicon compound includes a silicon-hydrogen bond or a silicon-oxygen bond.

Surface-modified nanoparticles of boehmite, and methods for preparing the same. Aluminum oxyhydroxide nanoparticles are surface modified by reaction with selected amounts of organic acids. In particular, the nanoparticle surface is modified by reactions with two or more different carboxylic acids, at least one of which is an organic carboxylic acid. The product is a surface modified boehmite nanoparticle that has an inorganic aluminum oxyhydroxide core, or part aluminum oxyhydroxide core and a surface-bonded organic shell. Organic carboxylic acids of this invention contain at least one carboxylic acid group and one carbon-hydrogen bond. One embodiment of this invention provides boehmite nanoparticles that have been surface modified with two or more acids one of which additional carries at least one reactive functional group. Another embodiment of this invention provides boehmite nanoparticles that have been surface modified with multiple acids one of which has molecular weight or average molecular weight greater than or equal to 500 Daltons. Yet, another embodiment of this invention provides boehmite nanoparticles that are surface modified with two or more acids one of which is hydrophobic in nature and has solubility in water of less than 15 by weight. The products of the methods of this invention have specific useful properties when used in mixture with liquids, as filler in solids, or as stand-alone entities.